by
Thomas Dworetzky, Contributing Reporter | January 23, 2019
RAPID was successfully tested in over 10 trials, and was used in stroke studies that include SWIFT PRIME, EXTEND IA, EXTEND, DAWN and DEFUSE 3 – and
is now installed on more than 4,000 scanners worldwide at over 1000 hospitals. More than 700 stroke centers adopted the solution in 2018 alone.
Samsung Neurologica introduced its
first new mobile CT in over a decade – since the CereTom – in late 2017 when it released its next-generation OmniTom mobile CT.
Ad Statistics
Times Displayed: 109945
Times Visited: 6642 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
“The OmniTom takes many of the key capabilities of CereTom and packages [them] in a modern solution,” Philip Sullivan, president and CEO of Samsung Neurologica, told HCB News at the time. “You truly get fixed CT imaging with a portable package.”
The OmniTom is a 16-slice scanner – up from the 8-slice CereTom. It also has a drive system with omnidirectional wheels that allow for a higher degree of mobility.
“The key thing about mobile CT is that you want to bring the imaging to the patient,” said Sullivan. “The CereTom was good at that, but the OmniTom is even better because you can get into those tight ICU rooms.”
The CereTom has become a mainstay in ambulances around the world to determine if a stroke is ischemic or hemorrhagic. It’s currently the standard for that indication, but Sullivan expects the OmniTom to eventually follow suit.
Back to HCB News
